Innate Antibacterial Activity in Female Genital Tract Secretions Is Associated with Increased Risk of HIV Acquisition

Rebecca Pellett Madan, Lindi Masson, Jessica Tugetman, Lise Werner, Anneke Grobler, Koleka Mlisana, Yungtai Lo, Denise Che, Kelly B. Arnold, Salim S Abdool Karim, Jo Ann S Passmore, Betsy Herold

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Greater inhibitory activity against Escherichia coli and levels of human β defensin (HBD)-2 in genital tract secretions predicted HIV acquisition in women in the HPTN 035 trial. We investigated whether higher levels of E. coli inhibitory activity and antimicrobial peptides in cervicovaginal lavage (CVL) samples predicted HIV acquisition in women in the CAPRISA 002 Acute Infection Study. E. coli inhibitory activity and antimicrobial peptides were quantified in CVL from a subset of CAPRISA 002 participants who did not seroconvert (n=39) and from seroconverting women prior to infection (n=17) and during acute infection (n=11). Women who acquired HIV had significantly greater preinfection CVL E. coli inhibitory activity (p=0.01) and HBD-1 levels (p=0.02) compared to women who remained uninfected. Preinfection E. coli inhibitory activity remained significantly associated with seroconversion following adjustment for the presence of bacterial vaginosis (OR 1.45; 95% CI 1.07, 1.97). Partial least squares discriminant analysis confirmed that preinfection CVL E. coli inhibitory activity, together with higher CVL concentrations of HBD-1 and secretory leukocyte protease inhibitor, distinguished seroconverters from nonseroconverters with 67% calibration accuracy. CVL concentrations of human neutrophil peptides (HNP) 1-3 increased significantly with acute infection (p=0.001) and correlated with plasma viral set point (r=0.66, p=0.03). E. coli inhibitory activity in genital tract secretions could provide a biomarker of HIV risk. The correlation between HNP 1-3 and viral set point merits further investigation of the relationship between mucosal inflammation during early HIV infection and disease progression.

Original languageEnglish (US)
Pages (from-to)1153-1159
Number of pages7
JournalAIDS Research and Human Retroviruses
Volume31
Issue number11
DOIs
StatePublished - Nov 1 2015

Fingerprint

Therapeutic Irrigation
HIV
Escherichia coli
Infection
Secretory Leukocyte Peptidase Inhibitor
Defensins
Bacterial Vaginosis
Peptides
Discriminant Analysis
Least-Squares Analysis
Calibration
HIV Infections
Disease Progression
Biomarkers
Inflammation

ASJC Scopus subject areas

  • Immunology
  • Virology
  • Infectious Diseases

Cite this

Innate Antibacterial Activity in Female Genital Tract Secretions Is Associated with Increased Risk of HIV Acquisition. / Pellett Madan, Rebecca; Masson, Lindi; Tugetman, Jessica; Werner, Lise; Grobler, Anneke; Mlisana, Koleka; Lo, Yungtai; Che, Denise; Arnold, Kelly B.; Karim, Salim S Abdool; Passmore, Jo Ann S; Herold, Betsy.

In: AIDS Research and Human Retroviruses, Vol. 31, No. 11, 01.11.2015, p. 1153-1159.

Research output: Contribution to journalArticle

Pellett Madan, R, Masson, L, Tugetman, J, Werner, L, Grobler, A, Mlisana, K, Lo, Y, Che, D, Arnold, KB, Karim, SSA, Passmore, JAS & Herold, B 2015, 'Innate Antibacterial Activity in Female Genital Tract Secretions Is Associated with Increased Risk of HIV Acquisition', AIDS Research and Human Retroviruses, vol. 31, no. 11, pp. 1153-1159. https://doi.org/10.1089/aid.2015.0011
Pellett Madan, Rebecca ; Masson, Lindi ; Tugetman, Jessica ; Werner, Lise ; Grobler, Anneke ; Mlisana, Koleka ; Lo, Yungtai ; Che, Denise ; Arnold, Kelly B. ; Karim, Salim S Abdool ; Passmore, Jo Ann S ; Herold, Betsy. / Innate Antibacterial Activity in Female Genital Tract Secretions Is Associated with Increased Risk of HIV Acquisition. In: AIDS Research and Human Retroviruses. 2015 ; Vol. 31, No. 11. pp. 1153-1159.
@article{f1612ebaafd34be1ba2f1c9939483925,
title = "Innate Antibacterial Activity in Female Genital Tract Secretions Is Associated with Increased Risk of HIV Acquisition",
abstract = "Greater inhibitory activity against Escherichia coli and levels of human β defensin (HBD)-2 in genital tract secretions predicted HIV acquisition in women in the HPTN 035 trial. We investigated whether higher levels of E. coli inhibitory activity and antimicrobial peptides in cervicovaginal lavage (CVL) samples predicted HIV acquisition in women in the CAPRISA 002 Acute Infection Study. E. coli inhibitory activity and antimicrobial peptides were quantified in CVL from a subset of CAPRISA 002 participants who did not seroconvert (n=39) and from seroconverting women prior to infection (n=17) and during acute infection (n=11). Women who acquired HIV had significantly greater preinfection CVL E. coli inhibitory activity (p=0.01) and HBD-1 levels (p=0.02) compared to women who remained uninfected. Preinfection E. coli inhibitory activity remained significantly associated with seroconversion following adjustment for the presence of bacterial vaginosis (OR 1.45; 95{\%} CI 1.07, 1.97). Partial least squares discriminant analysis confirmed that preinfection CVL E. coli inhibitory activity, together with higher CVL concentrations of HBD-1 and secretory leukocyte protease inhibitor, distinguished seroconverters from nonseroconverters with 67{\%} calibration accuracy. CVL concentrations of human neutrophil peptides (HNP) 1-3 increased significantly with acute infection (p=0.001) and correlated with plasma viral set point (r=0.66, p=0.03). E. coli inhibitory activity in genital tract secretions could provide a biomarker of HIV risk. The correlation between HNP 1-3 and viral set point merits further investigation of the relationship between mucosal inflammation during early HIV infection and disease progression.",
author = "{Pellett Madan}, Rebecca and Lindi Masson and Jessica Tugetman and Lise Werner and Anneke Grobler and Koleka Mlisana and Yungtai Lo and Denise Che and Arnold, {Kelly B.} and Karim, {Salim S Abdool} and Passmore, {Jo Ann S} and Betsy Herold",
year = "2015",
month = "11",
day = "1",
doi = "10.1089/aid.2015.0011",
language = "English (US)",
volume = "31",
pages = "1153--1159",
journal = "AIDS Research and Human Retroviruses",
issn = "0889-2229",
publisher = "Mary Ann Liebert Inc.",
number = "11",

}

TY - JOUR

T1 - Innate Antibacterial Activity in Female Genital Tract Secretions Is Associated with Increased Risk of HIV Acquisition

AU - Pellett Madan, Rebecca

AU - Masson, Lindi

AU - Tugetman, Jessica

AU - Werner, Lise

AU - Grobler, Anneke

AU - Mlisana, Koleka

AU - Lo, Yungtai

AU - Che, Denise

AU - Arnold, Kelly B.

AU - Karim, Salim S Abdool

AU - Passmore, Jo Ann S

AU - Herold, Betsy

PY - 2015/11/1

Y1 - 2015/11/1

N2 - Greater inhibitory activity against Escherichia coli and levels of human β defensin (HBD)-2 in genital tract secretions predicted HIV acquisition in women in the HPTN 035 trial. We investigated whether higher levels of E. coli inhibitory activity and antimicrobial peptides in cervicovaginal lavage (CVL) samples predicted HIV acquisition in women in the CAPRISA 002 Acute Infection Study. E. coli inhibitory activity and antimicrobial peptides were quantified in CVL from a subset of CAPRISA 002 participants who did not seroconvert (n=39) and from seroconverting women prior to infection (n=17) and during acute infection (n=11). Women who acquired HIV had significantly greater preinfection CVL E. coli inhibitory activity (p=0.01) and HBD-1 levels (p=0.02) compared to women who remained uninfected. Preinfection E. coli inhibitory activity remained significantly associated with seroconversion following adjustment for the presence of bacterial vaginosis (OR 1.45; 95% CI 1.07, 1.97). Partial least squares discriminant analysis confirmed that preinfection CVL E. coli inhibitory activity, together with higher CVL concentrations of HBD-1 and secretory leukocyte protease inhibitor, distinguished seroconverters from nonseroconverters with 67% calibration accuracy. CVL concentrations of human neutrophil peptides (HNP) 1-3 increased significantly with acute infection (p=0.001) and correlated with plasma viral set point (r=0.66, p=0.03). E. coli inhibitory activity in genital tract secretions could provide a biomarker of HIV risk. The correlation between HNP 1-3 and viral set point merits further investigation of the relationship between mucosal inflammation during early HIV infection and disease progression.

AB - Greater inhibitory activity against Escherichia coli and levels of human β defensin (HBD)-2 in genital tract secretions predicted HIV acquisition in women in the HPTN 035 trial. We investigated whether higher levels of E. coli inhibitory activity and antimicrobial peptides in cervicovaginal lavage (CVL) samples predicted HIV acquisition in women in the CAPRISA 002 Acute Infection Study. E. coli inhibitory activity and antimicrobial peptides were quantified in CVL from a subset of CAPRISA 002 participants who did not seroconvert (n=39) and from seroconverting women prior to infection (n=17) and during acute infection (n=11). Women who acquired HIV had significantly greater preinfection CVL E. coli inhibitory activity (p=0.01) and HBD-1 levels (p=0.02) compared to women who remained uninfected. Preinfection E. coli inhibitory activity remained significantly associated with seroconversion following adjustment for the presence of bacterial vaginosis (OR 1.45; 95% CI 1.07, 1.97). Partial least squares discriminant analysis confirmed that preinfection CVL E. coli inhibitory activity, together with higher CVL concentrations of HBD-1 and secretory leukocyte protease inhibitor, distinguished seroconverters from nonseroconverters with 67% calibration accuracy. CVL concentrations of human neutrophil peptides (HNP) 1-3 increased significantly with acute infection (p=0.001) and correlated with plasma viral set point (r=0.66, p=0.03). E. coli inhibitory activity in genital tract secretions could provide a biomarker of HIV risk. The correlation between HNP 1-3 and viral set point merits further investigation of the relationship between mucosal inflammation during early HIV infection and disease progression.

UR - http://www.scopus.com/inward/record.url?scp=84946718211&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946718211&partnerID=8YFLogxK

U2 - 10.1089/aid.2015.0011

DO - 10.1089/aid.2015.0011

M3 - Article

C2 - 26061218

AN - SCOPUS:84946718211

VL - 31

SP - 1153

EP - 1159

JO - AIDS Research and Human Retroviruses

JF - AIDS Research and Human Retroviruses

SN - 0889-2229

IS - 11

ER -